Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Postgraduate medical journal

• Publication date

  1995-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/pgmj.71.833.136PMID 7538216PMCID PMC2398180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

  2002cited by this paper
• Screening for prostatic carcinoma with prostate specific antigen.

  1997cited by this paper
• The American Cancer Society's National Prostate Cancer Detection Project.

  1994cited by this paper
• Benign prostatic hyperplasia: diagnosis and treatment (Clinical practice guideline no. 8; AHCPR publication no. 94-0582)

  1994cited by this paper
• Prostate cancer screening: accepting the consequences of PSA testing.

  1993cited by this paper
• Screening for prostate cancer

  1993cited by this paper
• Benign prostatic hyperplasia: newer approaches

  1993cited by this paper
• Screening for prostate cancer in 1993: is it appropriate, or not?

  1993cited by this paper
• Erkek infertilitesinde follikül stimüle edici hormon tedavisi

  1993cited by this paper
• Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen.

  1993cited by this paper
• Screening for prostate cancer in 1993: is it appropriate, or not?

  1993cited by this paper
• Intra-operative myocardial ischaemia detected by biplane transoesophageal echocardiography during transurethral prostatectomy.

  1993cited by this paper
• Prostate cancer: to screen or not to screen?

  1993cited by this paper
• Screening: reasons to be cautious.

  1993cited by this paper
• Screening for prostatic carcinoma with prostate specific antigen.

  1992cited by this paper
• Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease.

  1992cited by this paper
• Levels of prostate specific antigen that predict skeletal spread in prostate cancer.

  1992cited by this paper
• Haemodynamic evidence for cardiac stress during transurethral prostatectomy.

  1992cited by this paper
• The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen.

  1992cited by this paper
• A randomized, placebo-controlled multicenter study of the efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia.

  1992cited by this paper
• The effect of finasteride in men with benign prostatic hyperplasia.

  1992cited by this paper
• Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association.

  1992cited by this paper
• Laser ablation of the prostate in patients with benign prostatic hypertrophy.

  1992cited by this paper
• Screening in Health Care

  1991cited by this paper
• Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

  1991cited by this paper
• Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

  1991cited by this paper
• The epidemiology of prostatic cancer. Geographical distribution and time-trends.

  1991cited by this paper
• High prevalence of benign prostatic hypertrophy in the community.

  1991cited by this paper
• Pilot study of screening for prostate cancer in general practice.

  1991cited by this paper
• The American cancer society national prostate cancer detection project. Findings on the detection of early prostate cancer in 2425 men

  1991cited by this paper
• Rectal examination in general practice.

  1990cited by this paper
• Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention

  1990cited by this paper
• Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen.

  1990cited by this paper
• Assessment of volume measurement of the prostate using per-rectal ultrasonography.

  1989cited by this paper
• Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia.

  1989cited by this paper
• Symptom status and quality of life following prostatectomy.

  1988cited by this paper
• Prostatectomy: patients' perception and long-term follow-up.

  1988cited by this paper
• A population-based study of prostatectomy: outcomes associated with differing surgical approaches.

  1987cited by this paper
• The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study.

  1985cited by this paper
• Primary culture of prostatic region entoderm of human fetal sinus urogenitalis: Morphological, histochemical, and electrophoretic characteristics

  1982cited by this paper
• The natural history of untreated "prostatism".

  1981cited by this paper
• Purification of a human prostate specific antigen.

  1979cited by this paper
• Latent carcinoma of the prostate.

  1954cited by this paper

• Clinical Characteristics of African Men with Prostate Diseases in a Tertiary Centre in Western Kenya

  2014cites this paper
• The safety and efficacy of trans-vesical prostatectomy done at a primary general hospital setting in Ethiopia

  2008cites this paper
• Acute urinary retention: developing an A&E management pathway.

  2006cites this paper
• Effects of a shared protocol between urologists and general practitioners on referral patterns and initial diagnostic management of men with lower urinary tract symptoms in Italy: the Prostate Destination study

  2005cites this paper
• Diagnostic procedures by Italian general practitioners in response to lower urinary tract symptoms in male patients: a prospective study

  2004cites this paper
• Who Should Be Treated and How? Evidence-Based Medicine in Symptomatic BPH

  1999cites this paper
• An audit of prostate-specific antigen and clinical symptoms in general practice.

  1998cites this paper
• PSA-Screening beim Prostatakarzinom

  1998cites this paper
• Benign prostatic hyperplasia.

  1997cites this paper
• Elevated serum prostate-specific antigen and pancreatic carcinoma.

  1996cites this paper